Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.224
EU - Europa 4.712
AS - Asia 2.458
SA - Sud America 38
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 14
Totale 16.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.044
DE - Germania 904
CN - Cina 878
SE - Svezia 842
SG - Singapore 839
IE - Irlanda 668
IT - Italia 602
UA - Ucraina 530
RU - Federazione Russa 460
HK - Hong Kong 303
GB - Regno Unito 254
CA - Canada 173
VN - Vietnam 131
FI - Finlandia 122
AT - Austria 102
IN - India 71
FR - Francia 67
DK - Danimarca 64
ID - Indonesia 60
KR - Corea 59
JP - Giappone 36
NL - Olanda 30
BR - Brasile 29
TR - Turchia 27
BE - Belgio 21
MY - Malesia 21
EU - Europa 18
NZ - Nuova Zelanda 17
IR - Iran 16
PL - Polonia 13
AU - Australia 12
EG - Egitto 8
ES - Italia 7
CZ - Repubblica Ceca 6
MX - Messico 5
BG - Bulgaria 4
CL - Cile 4
HR - Croazia 4
HU - Ungheria 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
RS - Serbia 3
A1 - Anonimo 2
CH - Svizzera 2
CO - Colombia 2
GT - Guatemala 2
LB - Libano 2
NG - Nigeria 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 16.496
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.879
Woodbridge 819
Chandler 706
Singapore 666
Dublin 652
Jacksonville 543
Houston 525
Fairfield 455
Wilmington 446
Frankfurt am Main 433
Dearborn 424
Ashburn 353
Hong Kong 283
New York 270
Princeton 244
Milan 239
Santa Clara 228
Seattle 174
Nanjing 173
Boardman 170
Cambridge 137
Shanghai 116
Vienna 102
Lachine 89
Dong Ket 78
Altamura 73
Lawrence 71
Beijing 65
Jakarta 60
Guangzhou 59
Nanchang 59
Fremont 45
Andover 42
Shenyang 42
Grafing 40
Jinan 36
Toronto 36
Jiaxing 34
Nürnberg 33
San Diego 31
Helsinki 29
Los Angeles 27
Falls Church 26
Ottawa 26
Tianjin 25
Zhengzhou 25
Daejeon 24
Chicago 23
Kunming 23
Mountain View 23
Hangzhou 22
Hebei 22
Pune 22
Changsha 21
Brussels 20
Sacramento 19
Dallas 17
Leawood 16
Ningbo 14
Philadelphia 14
Edmonton 13
Huizen 13
Rome 13
Bergamo 12
Carate Brianza 12
Norwalk 12
Pasir Mas 12
Regensburg 12
Shinjuku 12
Phoenix 11
Taizhou 11
Auburn Hills 10
Hefei 10
Kiev 9
London 9
San Mateo 9
Yongin-si 9
Codroipo 8
Cagliari 7
Canazei 7
Washington 7
Wuhan 7
Changchun 6
Detroit 6
Fuzhou 6
Lissone 6
Mainz 6
Ankara 5
Auckland 5
Clarks Summit 5
Frederick 5
Haikou 5
Laurel 5
Melzo 5
Redmond 5
Secaucus 5
Seoul 5
Suwon 5
São Paulo 5
Tappahannock 5
Totale 11.688
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 311
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 301
Age-related changes in the function and structure of the peripheral sensory pathway in mice 300
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 296
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 287
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 245
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 239
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 233
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 218
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 216
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 207
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 207
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 203
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 202
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 200
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 198
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 197
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 191
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 187
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 186
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 182
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 181
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 180
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 179
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 178
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 177
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 173
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 172
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 171
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 169
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 166
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 166
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 165
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 165
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 164
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 164
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 163
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 160
Lipoplatin tm: a less neurotoxic formulation of cisplatin 159
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 157
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 156
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 155
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 155
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 155
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 154
Granulocytes in actively induced Lewis rat EAE 151
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 148
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 146
Erythropoietin both protects from and reverses experimental diabetic neuropathy 144
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 142
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 142
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 141
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 141
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 141
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 141
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 141
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 139
Regression of diabetic complications by islet transplantation in the rat 137
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 136
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 136
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 136
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 136
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 136
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 134
Multimodal experimental approach to the study of human neurological diseases 133
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 130
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 128
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 127
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 126
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 125
Effect of proteasome inhibition on the central and peripheral nervous system 125
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 125
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 124
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 123
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 121
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 120
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 118
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 116
Characterization of Glutamate Transporters in Peripheral Nervous System. 114
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 114
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 113
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 113
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 110
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 106
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 104
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 103
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 103
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 102
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib 101
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 101
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 99
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS 98
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 97
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 96
Biodistrubution and toxicology of two PFCs intravenously injected in rats 95
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 94
CHARACTERIZATION OF BORTEZOMIB- INDUCED PERIPHERAL NEUROPATHY IN EXPERIMENTAL ANIMAL MODELS 90
Different strains of mice are differently susceptible to cisplatin-induced painful peripheral neuropathy (cipn): role of pharmacogenomics? 89
Totale 15.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020896 0 0 0 0 0 0 0 186 265 212 199 34
2020/20212.346 128 76 259 252 205 197 265 197 205 194 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20252.135 283 607 355 210 350 119 203 8 0 0 0 0
Totale 17.399